Baeuerle Patrick 4
4 · Cullinan Oncology, Inc. · Filed Sep 9, 2021
Insider Transaction Report
Form 4
Baeuerle Patrick
See Remarks
Transactions
- Sale
Common Stock
2021-09-08$28.45/sh−11,000$312,950→ 0 total - Exercise/Conversion
Common Stock
2021-09-08$4.30/sh+11,000$47,300→ 11,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-09-08−11,000→ 240,114 totalExercise: $4.30Exp: 2030-10-28→ Common Stock (11,000 underlying)
Holdings
- 341,434(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 30, 2021.
- [F2]Shares held directly by APAK Solutions GmbH. The Reporting Person is managing director of APAK Solutions GmbH. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
- [F3]25% of the shares vested on September 1, 2019, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.